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Optimal drug-eluting stent implantation  
with the aid of optical coherence tomography  
in the stenotic lesion of ectatic coronary artery
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Young Joon Hong, Ju Han Kim, Youngkeun Ahn
Division of Cardiology, Chonnam National University Hospital, Gwangju, Korea
A 59-year-old man presented with 1 day his-
tory of intermittent angina and an elevated high 
sensitivity troponin measurement. He had received 
stent implantation with a 4.5 × 16 mm bare metal 
stent (BMS) at the proximal portion of the ectatic 
right coronary artery (RCA) 3 years prior to this. 
Urgent coronary angiography (CAG) demonstrated 
the severe stenosis in the distal RCA with patent 
of implanted BMS (Fig. 1A). The selection of ap-
propriate stent size and stent optimization to avoid 
under-expansion and malapposition due to the 
stenotic lesion of ectatic RCA led to an assessment 
with optical coherence tomography (OCT). OCT 
(Suppl. Video 1) demonstrated that distal reference 
lumen and external elastic lamina (EEL) diameter of 
4.67 mm and 5.20 mm, respectively (Fig. 1B). OCT also 
showed a minimal lumen area of 3.32 mm2 (Fig. 1C) 
and proximal reference lumen and EEL diameter of 
3.91 mm and 4.65 mm, respectively (Fig. 1D). The 
OCT assessment led to predilation with a 3.0 × 
× 15 mm balloon, and a 4.0 × 24 mm bioabsorbable 
polymer everolimus-eluting stent (SYNERGYTM, 
Boston Scientific, USA) implantation at 16 atmos-
phere. Postdilation was achieved with a 5.0 × 12 mm 
noncompliant balloon at up to 18 atmosphere in the 
distal portion of implanted drug eluting stent (DES). 
Repeated OCT assessment demonstrated (Suppl. 
Video 2) a minimal stent area of 11.92 mm2 (Fig. 1E), 
excellent stent expansion, and good strut apposition 
without edge dissection. Final CAG showed good 
distal flow without residual stenosis (Fig. 1F).
Percutaneous coronary intervention with DES 
for ectatic coronary artery is challenging due to 
stent optimization. This case highlights the im-
portant role OCT plays in the stent optimization 
for ectatic vessel.
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Figure 1. A. Angiographic assessment demonstrating severe stenosis in the distal right coronary artery (RCA) with 
ectasia and patent bare metal stent (BMS) in the proximal RCA (white arrow); B. Optical coherence tomography (OCT) 
assessment demonstrating distal reference lumen diameter of 4.67 mm and external elastic lamina (EEL) diameter 
of 5.20 mm; C. OCT cross-section demonstrating minimal lumen area (MLA) of 3.32 mm2; D. OCT demonstrating 
proximal reference lumen and EEL diameter of 3.91 mm and 4.65 mm, respectively; E. OCT demonstrating minimal 
stent area (MSA) of 11.92 mm2 and good stent apposition; F. Final angiogram demonstrating good distal flow without 
residual stenosis from treatment with 4.0 × 24 mm SYNERGYTM stent. 
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